Logo

Bio-Rad Acquires ProteOptics to Expand Proteomics Portfolio

Feb 27, 2006

NEW YORK, Feb. 27 (GenomeWeb News) - Bio-Rad said last week that it has acquired ProteOptics, an Israel-based maker of surface plasmon resonance technology.

 

Terms of the acquisition were not disclosed.

 

ProteOptics' technology involves the use of image analysis to track optical changes without the need of any molecular labeling in order to monitor biomolecular interactions, and is expected to expand Bio-Rad's proteomics' product offerings, Bio-Rad said.

Breaking News
The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.